Per Samuelsson

Biography

Per Samuelsson was appointed to the board of Oncopeptides in 2012. In addition to being a board member of Oncopeptides, Per is a partner at HealthCap, a life sciences venture capital business. Per has over 15 years investment banking experience, mainly with Aros Securities based in Sweden. At Aros Securities he held a number of roles including being a Director in the corporate finance department where he specialized in merger transactions, initial public offerings and equity incentive programs. Per also held the role of Head of Research at Aros Securities. Per holds an MSc in Engineering from the Institute of Technology in Linköping, Sweden. Born: 1961 Board Committees: Member of the Remuneration Committee Holdings in Oncopeptides: Nil Other current positions: Director of Ancilla AB, Cantando AB, HealthCap AB, HealthCap Aero Holdings GP AB, HealthCap Annex Fund I-II Bis GP AB, HealthCap Annex Fund I-II GP AB, Health-Cap Holdings GP AB, HealthCap Orx Holdings GP AB, HealthCap 1999 GP AB, HealthCap III Sidefund GP AB, HealthCap IV GP AB, Kip Jansson Film 1 AB, NVC Holding AB, RSPR Incentive AB, RSPR Pharma AB, SwedenBIO Service AB, Nordic Nanovector ASA and Targovax ASA. Independent in relation to the Company and its senior management, but not in relation to major shareholders. Partner in HealthCap and holder of directorships in a number of companies within the HealthCap Group.

Research Interest

His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.